These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33441001)

  • 21. Prevention of embolic stroke by catheter ablation of atrial fibrillation.
    Stöllberger C; Schneider B; Winkler-Dworak M; Finsterer J
    Eur J Neurol; 2008 Dec; 15(12):1419-20. PubMed ID: 19049566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should surgical ablation for atrial fibrillation be performed in patients with a significantly enlarged left atrium?
    Ad N; Henry L; Hunt S; Holmes SD
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):236-41. PubMed ID: 24183909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New Oral Anticoagulants During Catheter Ablation of Atrial Fibrillation. Experience With Rivaroxaban].
    Kazakov AI; Yashin SM; Lyan EV; Ayrapetyan AV
    Kardiologiia; 2015; 55(8):30-4. PubMed ID: 26761969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation ablation and left appendage closure in heart failure patients.
    Patel MR; Biviano AB
    Curr Opin Cardiol; 2015 May; 30(3):259-66. PubMed ID: 25807223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter ablation for asymptomatic atrial fibrillation?
    Kochhäuser S; Verma A
    Expert Rev Cardiovasc Ther; 2015 Mar; 13(3):243-8. PubMed ID: 25666169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Outcomes of Left Atrial Appendage Electrical Isolation in Patients With Nonparoxysmal Atrial Fibrillation: A Propensity Score-Matched Analysis.
    Romero J; Di Biase L; Mohanty S; Trivedi C; Patel K; Parides M; Alviz I; Diaz JC; Natale V; Sanchez J; Della Rocca DG; Yang R; Mohanty P; Gianni C; Horton R; Burkhardt D; Al-Ahmad A; Lakkireddy D; Natale A
    Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e008390. PubMed ID: 32998529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
    Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
    Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
    Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial.
    Verma A; Ha ACT; Kirchhof P; Hindricks G; Healey JS; Hill MD; Sharma M; Wyse DG; Champagne J; Essebag V; Wells G; Gupta D; Heidbuchel H; Sanders P; Birnie DH
    Am Heart J; 2018 Mar; 197():124-132. PubMed ID: 29447772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a need to continue anticoagulation following "successful" atrial fibrillation ablation?
    Levitt HL; Toor SZ; Coplan NL
    Prev Cardiol; 2009; 12(1):39-42. PubMed ID: 19301690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and design of a global registry to evaluate real-world clinical outcomes in patients with atrial fibrillation and high risk of stroke treated with left atrial appendage occlusion using the AMPLATZER amulet device-Perspective of available/ongoing registries of catheter-based LAA occlusion.
    Hildick-Smith D; Diener HC; Schmidt B; Paul V; Settergren M; Teiger E; Camm J; Tondo C; Landmesser U
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):540-547. PubMed ID: 28862376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse Clinical Events during Long-Term Follow-Up After Catheter Ablation of Atrial Fibrillation.
    Arai M; Okumura Y; Nagashima K; Watanabe I; Watanabe R; Wakamatsu Y; Otsuka N; Yagyu S; Kurokawa S; Ohkubo K; Nakai T; Yokoyama K; Ikeda A; Matsumoto N; Kunimoto S; Tachibana E; Iso K; Nomoto K; Tosaka T; Sonoda K; Hirayama A
    Int Heart J; 2019 Jul; 60(4):812-821. PubMed ID: 31308323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Holmqvist F; Simon D; Steinberg BA; Hong SJ; Kowey PR; Reiffel JA; Naccarelli GV; Chang P; Gersh BJ; Peterson ED; Piccini JP;
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25999401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation.
    Nademanee K; Amnueypol M; Lee F; Drew CM; Suwannasri W; Schwab MC; Veerakul G
    Heart Rhythm; 2015 Jan; 12(1):44-51. PubMed ID: 25257091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
    Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
    Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of stroke incidence with duty-cycled multielectrode-phased radiofrequency ablation of persistent atrial fibrillation results of the VICTORY AF Study.
    Hummel J; Verma A; Calkins H; Schwamm LH; Gress D; Wells D; Souza J; Hokanson RB; Hemingway L; Stromberg K; Hoyt R; Wickliffe A; DeLurgio D; Boersma L
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1289-1297. PubMed ID: 32270538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.